Cargando…
1578. Rifampicin Reduces Tedizolid Concentrations When Co-Administered in Healthy Volunteers
BACKGROUND: Tedizolid is an oxazolidinone used to treat skin and soft-tissue infections. Rifampicin is a rifamycin antibiotic which can also treat skin and soft-tissue infections, such as those caused by Staphylococcus aureus. Tedizolid and rifampicin could be therefore used concurrently to treat in...
Autores principales: | Lee, Lawrence, Hor Hee, Kim, Paton, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809180/ http://dx.doi.org/10.1093/ofid/ofz360.1442 |
Ejemplares similares
-
Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers
por: Flanagan, Shawn, et al.
Publicado: (2018) -
Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
por: Gidari, Anna, et al.
Publicado: (2020) -
LB1578. Fully Automated Real-Time PCR for Detection of Candida auris
por: Jiang, Alice, et al.
Publicado: (2022) -
Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
por: Shin, Yesong, et al.
Publicado: (2022) -
Characteristics of Tedizolid Non-susceptible Enterococcal Clinical Isolates
por: Dhand, Abhay, et al.
Publicado: (2017)